Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
Targeting intrinsically disordered proteins in rational drug discovery.
Falls in people with multiple sclerosis compared with falls in healthy controls.
"I knew what was going to happen if I did nothing and so I was going to do something": Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad.
ANALYSIS OF MULTIPLE SCLEROSIS LESIONS VIA SPATIALLY VARYING COEFFICIENTS.
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.
Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Sleep disturbances in patients with multiple sclerosis.
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
[Therapeutic options for autoimmune encephalomyelitis].
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review.
Is it time to revise the classification of geographical distribution of multiple sclerosis?
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Pituitary apoplexy presented with optic neuritis.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Pages
« first
‹ previous
…
423
424
425
426
427
428
429
430
431
…
next ›
last »